Saturday, 2 December 2017
Saturday, 23 September 2017
WORLD CHRONIC MYELOID LEUKAEMIA DAY 2017
terkulaasogo@gmail.com
World CHRONIC MYELOID LEUKAEMIA Day (CML) is held on September 22 every year and is a day dedicated to
raising awareness about leukaemia,
an increasingly common form of cancer. This campaign was initiated in 2008 to raise
public awareness on leukaemia in terms of symptom recognition, early diagnosis
and treatment.
Leukaemia
is increasing in incidence and is a potentially life-threatening disease, One
million people worldwide live with leukaemia and nearly 1,000 people are
diagnosed with the disease every day, but there continues to be very little
awareness of the signs and symptoms of leukaemia.
Increasing
awareness on leukaemia will allow people in Nigeria and around the world to have
better recognize its signs and symptoms, leading to earlier diagnosis and more
timely treatment. Greater awareness will also empower patients and their
families to demand specialist treatment and care from qualified leukaemia physicians
as well as gain access to the most up-to-date information, support and treatment.
It is
from the foregoing that LCPI is organising a symposium, rally its official
lunch to commemorate the World Chronic Myeloid Leukaemia Awareness Day to bring
the campaign home to help people become aware of the symptoms and life
threatening effect of this disease.
by
Terkula Asogo
Subscribe to:
Posts (Atom)
Hope for CML patients in Abuja, Nigeria
Few days ago we signed an MoU with the International CML Foundation (iCMLf) for a grant to provide affordable BCR-ABL testing for CML patie...
-
Few days ago we signed an MoU with the International CML Foundation (iCMLf) for a grant to provide affordable BCR-ABL testing for CML patie...
-
LEUKAEMIA CAREPLUS INITIATIVE (LCPI) NGO FOR PEOPLE LIVING WITH BLOOD AND LYMPHATIC CANCERS Cancer of all kind both solid and blood, ha...
-
It takes place every year on 4th February. World cancer day aims to save millions of preventable death each year by raising awareness and ed...






